Market outlook of the global clinical diagnostics market in APAC
Clinical diagnostics is a method of performing diagnostic tests by using instruments, assay reagents, and systems to identify a disease or pathological condition in a laboratory. As these diagnostic tools are easy to use and highly accessible, the market for clinical diagnostics in APAC is expected to surpass USD 16 billion by 2019. The advent of biomarker-based tests and the rising popularity of point-of-care (POC) tests in this region are expected to result in this market’s healthy growth during the forecast period.
Technavio’s market research analysts have estimated factors like the growing popularity of POC tests to impel market growth during the next five years. POC testing reduces the waiting time of test results and involves fewer or no follow up visits. Additionally, it improves the patient’s healthcare accessibility and also allows them to conduct tests by themselves with the help of some home-based health devices like ACCU-CHEK.
Product-based segmentation of the clinical diagnostics market in APAC
- POC
- Tissue diagnostic
- Clinical microbiology
- Immunodiagnostics
- Molecular diagnostics
- Hematology
In this market research report, Technavio’s analysts have estimated the POC testing segment to account for the highest market growth rate during the forecast period. This segment is envisaged to grow at a rate of approximately 12% owing to its ability to reduce the clinical operating time and the number of visits to the clinic.
Competitive landscape and key vendors
This market is dominated by large vendors like Roche and Qiagen, and offers tremendous growth opportunities to the vendors. Since the market in APAC is rapidly growing, the establishment of industries and headquarters in this region will foster the growth opportunities for the vendors.
Key vendors in this market are -
- Abbott
- Biomerieux
- Beckman Coulter Diagnostics
- Roche
- Qiagen
Other prominent vendors in this market are Amgenix International, BD, Cepheid, DiagCor, Hologic, Life Technologies, J. Mitra & Co Pvt. Ltd, Landwind Medical, Mindray, Randox Laboratories, Span Diagnostics, Snibe Diagnostics, Sysmex, Trivitron Healthcare, Tosoh Corporation, and URIT.
Growth drivers, challenges, and upcoming trends: Clinical diagnostics
Technavio’s analyst has estimated upcoming trends, like the privatization of the healthcare sector, to spur market growth during the forecast period. The government’s increasing preference for multisite practice in this region is expected to allow private providers to easily access physicians according to their convenience. Also, the introduction of 100% foreign investment by governments in India and China is expected to boost the hospital business segment during the forecast period.
This report provides a number of factors contributing to the adoption, limitations, and opportunities of the global clinical diagnostics market in APAC. It also offers an analysis of each factor and an estimation of the extent to which the factors are likely to impact the overall market growth.
Key questions answered in the report include
- What will the market size and the growth rate be in 2019?
- What are the key factors driving the global clinical diagnostics market in APAC?
- What are the key market trends impacting the growth of the global clinical diagnostics market in APAC?
- What are the challenges to market growth?
- Who are the key vendors in the global clinical diagnostics market in APAC?
- What are the market opportunities and threats faced by the vendors in the global clinical diagnostics market in APAC?
- Trending factors influencing the market shares of APAC?
- What are the key outcomes of the five forces analysis of the global clinical diagnostics market in APAC?
Technavio also offers customization on reports based on specific client requirement.
Related reports
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
PART 05: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 06: Impact of regulatory services
- Impact of regulatory services on clinical diagnostic devices
PART 07: Clinical diagnostics: Product pipeline
- Clinical diagnostics: Product pipeline
PART 08: Market segmentation by product
- Immunodiagnostics market in APAC
- POC diagnostics market in APAC
- Molecular diagnostics market in APAC
- Hematology devices market in APAC
- Tissue diagnostics market in APAC
- Clinical microbiology systems market in APAC
PART 09: Market drivers
- Early and accurate diagnosis of life-threatening diseases
- Market expansion
- POC home diagnostics
- Government funding
- Domestic manufacturing of devices in China
PART 10: Impact of drivers
PART 11: Market challenges
- Lack of infrastructure and skilled professionals
- Issues with intellectual property rights
- Availability of counterfeit IVD products
- Inaccuracy of conventional diagnostics
- Pricing policies and unfavorable reimbursement policies in China
PART 12: Impact of drivers and challenges
PART 13: Market trends
- Privatization and healthcare coverage
- Emergence of antibiotic-resistant pathogens
- Personalized medicines
- Next-generation technology and DNA microarrays
- Local distributors as intermediaries
PART 14: Vendor landscape
- Competitive scenario
- Market share analysis 2014
- Other prominent vendors
- PART 15: Key vendor analysis
- Abbott Diagnostics
- bioMérieux
- Beckman Coulter
- Qiagen
- Roche Diagnostics
PART 16: Appendix
PART 17: Explore Technavio